Randomized, Prospective, Placebo-Controlled Double-Blind Study of Dextrose Prolotherapy for Osteoarthritic Thumb and Finger (DIP, PIP, and Trapeziometacarpal) Joints: Evidence of Clinical Efficacy
- 1 August 2000
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in The Journal of Alternative and Complementary Medicine
- Vol. 6 (4), 311-320
- https://doi.org/10.1089/10755530050120673
Abstract
Objectives: To determine the clinical benefit of dextrose prolotherapy (injection of growth factors or growth factor stimulators) in osteoarthritic finger joints. Design: Prospective randomized double-blind placebo-controlled trial. Settings/Location: Outpatient physical medicine clinic. Subjects: Six months of pain history was required in each joint studied as well as one of the following: grade 2 or 3 osteophyte, grade 2 or 3 joint narrowing, or grade 1 osteophyte plus grade 1 joint narrowing. Distal interphalangeal (DIP), proximal interphalangeal (PIP), and trapeziometacarpal (thumb CMC) joints were eligible. Thirteen patients (with seventy-four symptomatic osteoarthitic joints) received active treatment, and fourteen patients (with seventy-six symptomatic osteoarthritic joints) served as controls. Intervention: One half milliliter (0.5 mL) of either 10% dextrose and 0.075% xylocaine in bacteriostatic water (active solution) or 0.075% xylocaine in bacteriostatic water (control solution) was injected on medial and lateral aspects of each affected joint. This was done at 0, 2, and 4 months with assessment at 6 months after first injection. Outcome Measures: One-hundred millimeter (100 mm) Visual Analogue Scale (VAS) for pain at rest, pain with joint movement and pain with grip, and goniometrically-measured joint flexion. Results: Pain at rest and with grip improved more in the dextrose group but not significantly. Improvement in pain with movement of fingers improved significantly more in the dextrose group (42% versus 15% with a p value of .027). Flexion range of motion improved more in the dextrose group (p = .003). Side effects were minimal. Conclusion: Dextrose prolotherapy was clinically effective and safe in the treatment of pain with joint movement and range limitation in osteoarthritic finger joints.Keywords
This publication has 31 references indexed in Scilit:
- Signal transduction by β1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptorBiochemical Journal, 1999
- Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesisKidney International, 1998
- Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting. The importance of drug and surgery costsArthritis & Rheumatism, 1997
- PRIMARY CULTURED CHONDROCYTES OF DIFFERENT ORIGINS RESPOND DIFFERENTLY TO bFGF AND TGF-βLife Sciences, 1997
- Effect of Growth Factors on the Proliferation of Ligament Fibroblasts from Skeletally Mature RabbitsConnective Tissue Research, 1997
- Increased production of PDGF by angiotensin and high glucose in human vascular endotheliumLife Sciences, 1996
- Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathyDiabetes, 1996
- Basic fibroblast growth factor stimulates articular cartilage enlargement in young rats in vivoJournal of Orthopaedic Research, 1996
- Stress signaling in yeastBioEssays, 1995
- New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progressionArthritis & Rheumatism, 1989